19939 results for «»
19939 results
Laura Busto
Vigo, Spain
Enjoy new step-by-step and hands-on training at #PCRLV 2022!
Promising Safety and Efficacy Results for Supraflex Cruz in HBR Subset Analysis from FIRE Trial, with 1-Month DAPT
03 Nov 2023
Dive into the PCR Imaging Valves Madrid 2024 Workshop Programme!
PCR Tokyo Valves 2024: Dive into the Scientific Programme!
What's on the Programme?
Intracardiac echocardiography for tricuspid interventions
01 Dec 2023
Watch the replay of this webinar with R. Hahn, M. I. Koerber, S. Lim, F. Praz and R. S. Von Bardeleben to learn about the latest innovation for imaging the tricuspid valve and much more.
The unimaginable evolution of interventional cardiology from imagination to imaging
07 Nov 2023
Faith is to believe what you do not see; the reward of this faith is to see what you believe... Read this editorial by Flavio Ribichini, Martine Gilard and Salvatore Brugaletta which introduces this section dedicated to cardiovascular imaging. ...
AHA 2023: get the interventional cardiology perspective!
11 Nov 2023
Stay up to date with what is new and hot in interventional cardiology at #AHA23 in Philadelphia.
ORBITA-2 - Percutaneous coronary intervention for stable angina: A randomized, placebo-controlled trial
12 Nov 2023
Luis Ortega Paz interviews Rasha Al-Lamee and Christopher Rajkumar on the results of ORBITA-2 randomized placebo-controlled trial, which were presented at the AHA 2023 Congress in Philadelphia.
Author
Author
Author
Gianluigi Bisleri
Toronto, Canada
Geraldine Ong
Toronto, Canada
Dapagliflozin in acute myocardial infarction: Cardiometabolic benefits without impact on cardiovascular death or heart failure hospitalization: The jury is still out
14 Nov 2023
Luis Ortega Paz provides his take on DAPA-MI - A registry-based randomized trial of dapagliflozin in patient with acute myocardial infarction without diabetes, which was presented by Stefan James at AHA 2023 in Philadelphia.
Author
Half-dose tenecteplase or primary PCI in older patients with ST-elevation myocardial infarction: The STREAM-2 1-year mortality follow-up results
15 Nov 2023
Aaysha Cader interviews Peter Sinnaeve on the STREAM-2 1-year mortality follow-up results, which were presented at the AHA 2023 Congress in Philadelphia.
Results suggest that a pharmaco-invasive strategy provides an alternative for older STEMI patients unable to undergo primary PCI.
Author
Author
Peter Sinnaeve
Leuven, Belgium
Nightmare in mitral valve interventions: sharing solutions together
18 Feb 2024 – From PCR Tokyo Valves 2024
This selection of cases showcase nightmare scenarios during mitral valve interventions. Find out what difficulties might arise during MitraClip procedure, and learn how to prevent complications through optimal treatments and bailouts.
Mitral valve interventions for complex anatomy
17 Feb 2024 – From PCR Tokyo Valves 2024
Consult this session on to learn more about how to manage complex anatomy and complications during mitral valve interventions. Discover compelling cases such as a valve-in-ring TMVR in a fluoroscopically invisible ring, PASCAL for bailout of MitraClip single-leaflet device attachment, and more!
Rapid-fire - Complications in SHD interventions
17 Feb 2024 – From PCR Tokyo Valves 2024
Learn more about complications related to structural heart disease interventions through this rapid-fire series of cases. Discover cases such as a cardiac arrest due to coronary artery obstruction two days after TAVI using a balloon-expandable valve, an aortic stenosis case switched to surgery due to severe...
Rapid-fire - Mitral TEER for complex situations
18 Feb 2024 – From PCR Tokyo Valves 2024
This series of rapid-fire submitted cases focuses on mitral TEER for complex situations. Learn about creative solutions to these situations such as clip inversion grasping, independent leaflet grasping with a CGA system, and more!
Rapid-fire - Mitral TEER for special situations
17 Feb 2024 – From PCR Tokyo Valves 2024
Gain valuable insights into the possible complications of Mitral Transcatheter Edge-to-Edge Repair (TEER) in the first part of this session rapid-fire submission cases [in Japanese].